• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A1选择性腺苷拮抗剂8-环戊基-1,3-二丙基黄嘌呤与大鼠脑膜的结合。

Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.

作者信息

Bruns R F, Fergus J H, Badger E W, Bristol J A, Santay L A, Hartman J D, Hays S J, Huang C C

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):59-63. doi: 10.1007/BF00165037.

DOI:10.1007/BF00165037
PMID:3574492
Abstract

8-Cyclopentyl-1,3-dipropylxanthine (PD 116,948) is a very potent, very A1-selective adenosine antagonist, with a Ki of 0.46 nM in 3H-CHA binding to A1 receptors in rat whole brain membranes and 340 nM in 3H-NECA binding to A2 receptors in rat striatal membranes. Its 740-fold A1-selectivity is the highest reported for an adenosine antagonist. 3H-PD 116,948 (117 Ci/mmol) was prepared by reduction of the diallyl analog. 3H-PD 116,948 bound to a single site in rat whole brain membranes, with a Bmax of 46 pmol/g wet weight and Kd of 0.42 nM. Nonspecific binding was extremely low, amounting to about 3% of total binding under standard conditions and less than 1% when higher tissue concentrations were used. Affinities of compounds for inhibition of 3H-PD 116,948 binding were highly consistent with an A1 adenosine receptor. Antagonists were equally potent in 3H-PD 116,948 binding and in 3H-CHA binding, while agonists were consistently about 12-fold more potent in 3H-CHA binding. Hill coefficients were 1.0 for antagonists and about 0.65 for agonists. 3H-PD 116,948 should be a useful antagonist ligand for adenosine A1 receptors.

摘要

8-环戊基-1,3-二丙基黄嘌呤(PD 116,948)是一种强效、高A1选择性的腺苷拮抗剂,在大鼠全脑膜中与A1受体的3H-CHA结合的Ki为0.46 nM,在大鼠纹状体膜中与A2受体的3H-NECA结合的Ki为340 nM。其740倍的A1选择性是已报道的腺苷拮抗剂中最高的。3H-PD 116,948(117 Ci/mmol)通过二烯丙基类似物的还原制备。3H-PD 116,948与大鼠全脑膜中的单一位点结合,Bmax为46 pmol/g湿重,Kd为0.42 nM。非特异性结合极低,在标准条件下约占总结合的3%,当使用更高的组织浓度时不到1%。化合物对3H-PD 116,948结合的抑制亲和力与A1腺苷受体高度一致。拮抗剂在3H-PD 116,948结合和3H-CHA结合中的效力相同,而激动剂在3H-CHA结合中的效力始终约高12倍。拮抗剂的希尔系数为1.0,激动剂约为0.65。3H-PD 116,948应该是一种用于腺苷A1受体的有用拮抗剂配体。

相似文献

1
Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.A1选择性腺苷拮抗剂8-环戊基-1,3-二丙基黄嘌呤与大鼠脑膜的结合。
Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):59-63. doi: 10.1007/BF00165037.
2
PD 115,199: an antagonist ligand for adenosine A2 receptors.PD 115,199:一种腺苷A2受体的拮抗剂配体。
Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):64-9. doi: 10.1007/BF00165038.
3
Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.基于黄嘌呤和吡唑并吡啶的拮抗剂揭示的脑腺苷A1受体药理学中的物种差异。
Br J Pharmacol. 1997 Nov;122(6):1202-8. doi: 10.1038/sj.bjp.0701465.
4
Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine.脑膜中的腺苷受体:N6-环己基[3H]腺苷和1,3-二乙基-8-[3H]苯基黄嘌呤的结合
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5547-51. doi: 10.1073/pnas.77.9.5547.
5
Identification of A1 and A2 adenosine receptors in the rat spinal cord.大鼠脊髓中A1和A2腺苷受体的鉴定。
J Pharmacol Exp Ther. 1987 Sep;242(3):905-10.
6
KW-3902, a selective high affinity antagonist for adenosine A1 receptors.KW-3902,一种腺苷A1受体的选择性高亲和力拮抗剂。
Br J Pharmacol. 1996 Apr;117(8):1645-52. doi: 10.1111/j.1476-5381.1996.tb15335.x.
7
Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.MgCl₂ 和 Gpp(NH)p 对拮抗剂和激动剂放射性配体与腺苷 A1 受体结合的影响比较。
Acta Pharmacol Sin. 2003 Aug;24(8):729-40.
8
Differential binding properties of adenosine receptor agonists and antagonists in brain.脑内腺苷受体激动剂和拮抗剂的差异结合特性
J Neurochem. 1983 Aug;41(2):367-74. doi: 10.1111/j.1471-4159.1983.tb04752.x.
9
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.用[3H]NECA标记的大鼠纹状体膜中A2腺苷受体的特性研究。
Mol Pharmacol. 1986 Apr;29(4):331-46.
10
Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.选择性腺苷 A2 受体拮抗剂[3H]KF17837S 与大鼠脑膜的结合。
Mol Pharmacol. 1994 Nov;46(5):817-22.

引用本文的文献

1
A bibliometric study of the most-cited research articles and reviews in Naunyn-Schmiedeberg's Archives of Pharmacology (1969-2024).对《瑙恩-施米德贝格药理学文献》(1969 - 2024年)中被引用次数最多的研究文章和综述的文献计量学研究。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 1. doi: 10.1007/s00210-025-04471-7.
2
Design, synthesis and evaluation of amino-3,5-dicyanopyridines and thieno[2,3-b]pyridines as ligands of adenosine A receptors for the potential treatment of epilepsy.氨基-3,5-二氰基吡啶和噻吩并[2,3-b]吡啶作为腺苷A受体配体用于癫痫潜在治疗的设计、合成与评估
Med Chem Res. 2022;31(8):1277-1297. doi: 10.1007/s00044-022-02908-9. Epub 2022 May 24.
3

本文引用的文献

1
[3H]5'-N-ethylcarboxamide adenosine binds to both Ra and Ri adenosine receptors in rat striatum.[3H]5'-N-乙基羧酰胺腺苷与大鼠纹状体中的Ra和Ri腺苷受体均有结合。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Mar;325(3):218-25. doi: 10.1007/BF00495947.
2
Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists.腺苷受体结合:构效分析产生了极具效力的黄嘌呤拮抗剂。
Proc Natl Acad Sci U S A. 1983 Apr;80(7):2077-80. doi: 10.1073/pnas.80.7.2077.
3
Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5'-guanylylimidodiphosphate or N-ethylmaleimide.
multimodal imaging of adenosine A receptors in neuroinflammation after experimental stroke.
实验性中风后神经炎症中腺苷 A 受体的多模态成像。
Theranostics. 2021 Jan 1;11(1):410-425. doi: 10.7150/thno.51046. eCollection 2021.
4
C3 amino-substituted chalcone derivative with selective adenosine A receptor affinity in the micromolar range.具有微摩尔范围内选择性腺苷 A 受体亲和力的 C3 氨基取代查尔酮衍生物。
Chem Zvesti. 2021;75(4):1581-1605. doi: 10.1007/s11696-020-01414-9. Epub 2020 Nov 17.
5
Methoxy substituted 2-benzylidene-1-indanone derivatives as A and/or A AR antagonists for the potential treatment of neurological conditions.甲氧基取代的2-亚苄基茚满-1-酮衍生物作为A和/或A AR拮抗剂用于神经疾病的潜在治疗。
Medchemcomm. 2019 Jan 8;10(2):300-309. doi: 10.1039/c8md00540k. eCollection 2019 Feb 1.
6
Dual Influence of Endocannabinoids on Long-Term Potentiation of Synaptic Transmission.内源性大麻素对突触传递长时程增强的双重影响。
Front Pharmacol. 2017 Dec 19;8:921. doi: 10.3389/fphar.2017.00921. eCollection 2017.
7
Adenosine Receptors: The Contributions by John W. Daly.腺苷受体:约翰·W·戴利的贡献
Heterocycles. 2009;79(1):73-83. doi: 10.3987/COM-08-S(D)Memoire-2.
8
Hide and seek: a comparative autoradiographic in vitro investigation of the adenosine A3 receptor.捉迷藏:腺苷A3受体的体外放射自显影比较研究
Eur J Nucl Med Mol Imaging. 2015 May;42(6):928-39. doi: 10.1007/s00259-014-2985-2. Epub 2015 Mar 5.
9
Adenosine and inosine exert cytoprotective effects in an in vitro model of liver ischemia-reperfusion injury.腺嘌呤核苷和次黄嘌呤在肝缺血再灌注损伤的体外模型中发挥细胞保护作用。
Int J Mol Med. 2013 Feb;31(2):437-46. doi: 10.3892/ijmm.2012.1203. Epub 2012 Dec 4.
10
Riboflavin: Inhibitory Effects on Receptors, G-Proteins, and Adenylate Cyclase.核黄素:对受体、G蛋白和腺苷酸环化酶的抑制作用。
Drug Dev Res. 1997 Oct 1;42(2):98-108. doi: 10.1002/(SICI)1098-2299(199710)42:2<98::AID-DDR6>3.0.CO;2-K.
激动剂和拮抗剂对抑制性腺苷受体的亲和力会受到5'-鸟苷酰亚胺二磷酸或N-乙基马来酰亚胺的相互影响。
J Biol Chem. 1983 Feb 25;258(4):2334-9.
4
Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes.鸟嘌呤核苷酸和阳离子对[3H]环己基腺苷及[3H]二乙苯基黄嘌呤与脑膜中腺苷A1受体结合的调节作用
Mol Pharmacol. 1982 Mar;21(2):329-35.
5
Biochemical characterization of putative central purinergic receptors by using 2-chloro[3H]adenosine, a stable analog of adenosine.使用腺苷的稳定类似物2-氯[3H]腺苷对假定的中枢嘌呤能受体进行生化特性分析。
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6892-6. doi: 10.1073/pnas.77.11.6892.
6
Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine.脑膜中的腺苷受体:N6-环己基[3H]腺苷和1,3-二乙基-8-[3H]苯基黄嘌呤的结合
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5547-51. doi: 10.1073/pnas.77.9.5547.
7
Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.用(-)[³H]N6-苯基异丙基腺苷对大鼠脑内腺苷受体进行表征。
Naunyn Schmiedebergs Arch Pharmacol. 1980 Sep;313(3):179-87. doi: 10.1007/BF00505731.
8
Reciprocal modulation of agonist and antagonist binding to inhibitory adenosine receptors by 5'-guanylylimidodiphosphate and monovalent cations.5'-鸟苷酰亚胺二磷酸和单价阳离子对激动剂和拮抗剂与抑制性腺苷受体结合的相互调节作用。
J Neurosci. 1984 Oct;4(10):2472-6. doi: 10.1523/JNEUROSCI.04-10-02472.1984.
9
Two affinity states of Ri adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding.脑膜中Ri腺苷受体的两种亲和状态。鸟嘌呤核苷酸和温度对放射性配体结合影响的分析。
Mol Pharmacol. 1984 Jul;26(1):1-9.
10
Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue.评估A-1选择性腺苷放射性配体环戊基腺苷(CPA)与大鼠脑组织的结合情况。
Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):179-83. doi: 10.1007/BF00511410.